Publication bias and hidden multiple hypotheses testing distort the assessment of the true value of biomarkers. The authors of this article propose that a registry should be created for biomarker studies initially focused on studies that use specimens from randomized trials, as a means to alleviate the limitations associated with both publication bias and multiple hypotheses testing.
- Fabrice Andre
- Lisa M. McShane
- Lajos Pusztai